185 related articles for article (PubMed ID: 25257978)
1. A test of the stress-buffering model of social support in smoking cessation: is the relationship between social support and time to relapse mediated by reduced withdrawal symptoms?
Creswell KG; Cheng Y; Levine MD
Nicotine Tob Res; 2015 May; 17(5):566-71. PubMed ID: 25257978
[TBL] [Abstract][Full Text] [Related]
2. A bupropion smoking cessation clinical trial for cancer patients.
Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
[TBL] [Abstract][Full Text] [Related]
3. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.
Kotlyar M; Drone D; Thuras P; Hatsukami DK; Brauer L; Adson DE; al'Absi M
Nicotine Tob Res; 2011 Jun; 13(6):492-7. PubMed ID: 21378081
[TBL] [Abstract][Full Text] [Related]
4. Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
Brown RA; Niaura R; Lloyd-Richardson EE; Strong DR; Kahler CW; Abrantes AM; Abrams D; Miller IW
Nicotine Tob Res; 2007 Jul; 9(7):721-30. PubMed ID: 17577801
[TBL] [Abstract][Full Text] [Related]
5. Bupropion and cognitive behavioral therapy for weight-concerned women smokers.
Levine MD; Perkins KA; Kalarchian MA; Cheng Y; Houck PR; Slane JD; Marcus MD
Arch Intern Med; 2010 Mar; 170(6):543-50. PubMed ID: 20308641
[TBL] [Abstract][Full Text] [Related]
6. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
7. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
Piper ME; Vasilenko SA; Cook JW; Lanza ST
Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
[TBL] [Abstract][Full Text] [Related]
8. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
9. A multi-level analysis of non-significant counseling effects in a randomized smoking cessation trial.
McCarthy DE; Piasecki TM; Jorenby DE; Lawrence DL; Shiffman S; Baker TB
Addiction; 2010 Dec; 105(12):2195-208. PubMed ID: 20840173
[TBL] [Abstract][Full Text] [Related]
10. Psychological mediators of bupropion sustained-release treatment for smoking cessation.
McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Baker TB
Addiction; 2008 Sep; 103(9):1521-33. PubMed ID: 18783504
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Robinson JD; Li L; Chen M; Lerman C; Tyndale RF; Schnoll RA; Hawk LW; George TP; Benowitz NL; Cinciripini PM
Psychol Addict Behav; 2019 Mar; 33(2):105-116. PubMed ID: 30614717
[TBL] [Abstract][Full Text] [Related]
12. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
[TBL] [Abstract][Full Text] [Related]
13. Mediators of the effect of nicotine pre-treatment on quitting smoking.
Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
[TBL] [Abstract][Full Text] [Related]
14. Preventing Postpartum Smoking Relapse: A Randomized Clinical Trial.
Levine MD; Cheng Y; Marcus MD; Kalarchian MA; Emery RL
JAMA Intern Med; 2016 Apr; 176(4):443-52. PubMed ID: 26998789
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
[TBL] [Abstract][Full Text] [Related]
16. Post-quit stress mediates the relation between social support and smoking cessation among socioeconomically disadvantaged adults.
Bandiera FC; Atem F; Ma P; Businelle MS; Kendzor DE
Drug Alcohol Depend; 2016 Jun; 163():71-6. PubMed ID: 27085499
[TBL] [Abstract][Full Text] [Related]
17. Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial.
Becoña E; Martínez-Vispo C; Senra C; López-Durán A; Rodríguez-Cano R; Fernández Del Río E
BMC Psychiatry; 2017 Apr; 17(1):134. PubMed ID: 28390417
[TBL] [Abstract][Full Text] [Related]
18. Tobacco withdrawal components and their relations with cessation success.
Piper ME; Schlam TR; Cook JW; Sheffer MA; Smith SS; Loh WY; Bolt DM; Kim SY; Kaye JT; Hefner KR; Baker TB
Psychopharmacology (Berl); 2011 Aug; 216(4):569-78. PubMed ID: 21416234
[TBL] [Abstract][Full Text] [Related]
19. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
20. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
